Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer

NCT01470742 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped We stop because of problems such as insurance.

Conditions

Gastric Cancer

Interventions

DRUG: XELOX
DRUG: XELODA

Sponsor

Samsung Medical Center